Tanvex BioPharma Inc
TWSE:6541
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tanvex BioPharma Inc
TWSE:6541
|
KY |
|
Encompass Health Corp
NYSE:EHC
|
US |
|
Transition Metals Corp
XTSX:XTM
|
CA |
|
Toast Inc
F:71Y
|
US |
|
Capral Ltd
ASX:CAA
|
AU |
|
P
|
Pearson PLC
XMUN:PES
|
UK |
|
S
|
Sumitomo Realty & Development Co Ltd
OTC:SURDF
|
JP |
|
K
|
Kajima Corp
F:KAJ
|
JP |
|
C
|
Cheil Electric Wiring Devices Co Ltd
KOSDAQ:199820
|
KR |
|
G
|
Guangdong Mingzhu Group Co Ltd
SSE:600382
|
CN |
|
Ark Restaurants Corp
NASDAQ:ARKR
|
US |
|
Sonoco Products Co
NYSE:SON
|
US |
|
G
|
Glencore PLC
F:8GC
|
CH |
|
Anacomp Inc
OTC:ANMP
|
US |
|
A
|
Alibaba Group Holding Ltd
SWB:AHLA
|
HK |
|
D
|
Downer EDI Ltd
NZX:DOW
|
AU |
Bankruptcy Probability
Tanvex BioPharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Tanvex BioPharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KY |
|
Tanvex BioPharma Inc
TWSE:6541
|
8B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Tanvex BioPharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Tanvex BioPharma Inc has total debt of 1.5B TWD. This includes both short-term (135m TWD) and long-term (1.4B TWD) debt.
You can find a full breakdown on its Balance Sheet.